|
9 Companies |
|
7 Products |
|
7 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
5 News |
|
- Trial termination: Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation (clinicaltrials.gov) - May 2, 2016
P2, N=12, Terminated, Sponsor: St. Jude Children's Research Hospital
Active, not recruiting --> Terminated; Investigator's decision.
- Enrollment closed, Enrollment change, Trial primary completion date: Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation (clinicaltrials.gov) - Oct 30, 2015
P2, N=12, Active, not recruiting, Sponsor: St. Jude Children's Research Hospital
Active, not recruiting --> Terminated; Investigator's decision. Recruiting --> Active, not recruiting | N=18 --> 12 | Trial primary completion date: Jan 2018 --> Apr 2015
- Enrollment open: Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation (clinicaltrials.gov) - Oct 17, 2014
P2, N=18, Recruiting, Sponsor: St. Jude Children's Research Hospital
Recruiting --> Active, not recruiting | N=18 --> 12 | Trial primary completion date: Jan 2018 --> Apr 2015 Not yet recruiting --> Recruiting
- New P2 trial: Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation (clinicaltrials.gov) - Oct 10, 2014
P2, N=18, Not yet recruiting, Sponsor: St. Jude Children's Research Hospital
- Trial completion: PETAML: PET-CT in AML for Detection of Extramedullary AML Manifestations (clinicaltrials.gov) - Sep 15, 2013
P=N/A, N=93, Completed, Sponsor: Technische Universit
Not yet recruiting --> Recruiting Recruiting --> Completed